Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer

NCT00057837 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

140

Enrollment

NETWORK

Sponsor class

Conditions

Extensive Stage Small Cell Lung Cancer

Interventions

BIOLOGICAL: G-CSF
DRUG: Cisplatin
DRUG: Etoposide
DRUG: Irinotecan
DRUG: Topotecan

Sponsor

Eastern Cooperative Oncology Group

Collaborators

[object Object]